Skip directly to search Skip directly to A to Z list Skip directly to site content
CDC Home

Volume 16, Number 3—March 2010


Serologic Markers for Detecting Malaria in Areas of Low Endemicity, Somalia, 2008

Teun BousemaComments to Author , Randa M. Youssef, Jackie Cook, Jonathan Cox, Victor A. Alegana, Jamal Amran, Abdisalan M. Noor, Robert W. Snow, and Chris Drakeley
Author affiliations: London School of Hygiene and Tropical Medicine, London, UK (T. Bousema, J. Cook, J. Cox, C. Drakeley); University of Alexandria, Alexandria, Egypt (R.M. Youssef); Kenya Medical Research Institute–Wellcome Trust Research Programme, Nairobi, Kenya (R.M. Youssef, V.A. Alegana, J. Amran, A.M. Noor, R.W. Snow); Roll Back Malaria–World Health Organization, Hargeisa, Somalia (J. Amran); University of Oxford, Oxford, UK (A.M. Noor, R.W. Snow)

Main Article

Table 2

Immune responses against Plasmodium falciparum and P. vivax in study participants, by village, Somalia, 2008*

333.9 (271.4–463.9) 342.4 (280.1–374.8) 291.5 (248.7–393.3) 0.39
AMA-1 5.2 (13/252) 7.4 (11/149) 12.8 (85/665) 0.001
151.5 (146.0–202.1) 183.5 (155.7–275.7) 227.1 (184.6–390.8) 0.10

*IQR, interquartile range (25th–75th percentile); MSP-1, merozoite surface protein 1; AMA-1, apical membrane antigen 1.
†Values are % prevalence (no. positive/no. tested) or approximate median titer (IQR) only for seropositive persons unless otherwise indicated.
‡Adjusted for age and correlations between observations from the same household, when applicable.

Main Article

Top of Page The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO